Researchers at Case Western Reserve University, University Hospitals and Houston Methodist will harness the power of artificial intelligence (AI) to more accurately predict risk of heart failure and ...
A clinical trial of more than 3,600 patients evaluated for chest pain showed that fatty liver disease was linked to nearly ...
India, June 2 -- A large multicenter clinical trial has found that individuals with hepatic steatosis-commonly known as fatty ...
Researchers at Mass General Brigham Heart and Vascular Institute found that people with hepatic steatosis, commonly called "fatty liver disease," have a higher amount of noncalcified, rupture-prone ...
Photo Credit: Adapted from Koo BK. Artificial intelligence-enabled quantitative plaque and hemodynamic analysis for predicting acute coronary syndrome risk and prevention strategy: the EMERALD II ...
BOSTON--(BUSINESS WIRE)--Elucid has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PlaqueIQ™ imaging analysis software to help physicians diagnose ...
Individuals with hepatic steatosis appeared to have higher amounts of noncalcified coronary plaque and were almost twice as ...
An artificial intelligence (AI)-assisted algorithm that incorporates information about inflammation detected on coronary CT angiography (CCTA) may help identify patients who require more-intensive ...
April 13, 2007 (New York, NY) - A new type of iodine-based contrast agent that interacts with activated macrophages may one day be used in humans during multislice computed tomography to identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results